产品: 磷酸化 JAK2 (Tyr1007) 抗体
货号: AF3022
描述: Rabbit polyclonal antibody to Phospho-JAK2 (Tyr1007)
应用: WB IHC IF/ICC
文献验证: WB
反应: Human, Mouse, Rat
预测: Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus
蛋白号: O60674
RRID: AB_2834429

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1300 现货
 100ul RMB¥ 2400 现货
 200ul RMB¥ 3200 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:1000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
Phospho-JAK2 (Tyr1007) Antibody detects endogenous levels of JAK2 only when phosphorylated at Tyrosine 1007.
RRID:
AB_2834429
引用格式: Affinity Biosciences Cat# AF3022, RRID:AB_2834429.
偶联:
Unconjugated.
纯化:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

JAK 2; JAK-2; JAK2; JAK2_HUMAN; Janus Activating Kinase 2; Janus kinase 2 (a protein tyrosine kinase); Janus kinase 2; JTK 10; JTK10; kinase Jak2; OTTHUMP00000043260; THCYT3; Tyrosine protein kinase JAK2; Tyrosine-protein kinase JAK2;

抗原和靶标

免疫原:

A synthesized peptide derived from human JAK2 around the phosphorylation site of Tyr1007.

基因/基因ID:
描述:
This gene product is a protein tyrosine kinase involved in a specific subset of cytokine receptor signaling pathways. It has been found to be constituitively associated with the prolactin receptor and is required for responses to gamma interferon.

研究领域

· Cellular Processes > Cell growth and death > Necroptosis.   (View pathway)

· Cellular Processes > Cellular community - eukaryotes > Signaling pathways regulating pluripotency of stem cells.   (View pathway)

· Environmental Information Processing > Signal transduction > PI3K-Akt signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > Jak-STAT signaling pathway.   (View pathway)

· Human Diseases > Drug resistance: Antineoplastic > EGFR tyrosine kinase inhibitor resistance.

· Human Diseases > Infectious diseases: Parasitic > Leishmaniasis.

· Human Diseases > Infectious diseases: Parasitic > Toxoplasmosis.

· Human Diseases > Infectious diseases: Bacterial > Tuberculosis.

· Human Diseases > Infectious diseases: Viral > Measles.

· Human Diseases > Infectious diseases: Viral > Influenza A.

· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.

· Human Diseases > Cancers: Overview > Pathways in cancer.   (View pathway)

· Organismal Systems > Immune system > Chemokine signaling pathway.   (View pathway)

· Organismal Systems > Immune system > Th1 and Th2 cell differentiation.   (View pathway)

· Organismal Systems > Immune system > Th17 cell differentiation.   (View pathway)

· Organismal Systems > Nervous system > Cholinergic synapse.

· Organismal Systems > Endocrine system > Prolactin signaling pathway.   (View pathway)

· Organismal Systems > Endocrine system > Adipocytokine signaling pathway.

文献引用

1). Targeted pharmacokinetics and bioinformatics screening strategy reveals JAK2 as the main target for Xin-Ji-Er-Kang in treatment of MIR injury. Biomedicine & Pharmacotherapy, 2022 (PubMed: 36271569) [IF=6.9]

Application: WB    Species: Human    Sample:

Fig. 5. Effects of XJEK on JAK2/STAT1/STAT3 pathway and myocardial cell apoptosis after MIR injury. A Representative figure of JAK2, pJAK2, STAT3, pSTAT3, STAT1, pSTAT1 protein. B-E Quantitative analyses of JAK2, pJAK2, STAT3, pSTAT3, STAT1, pSTAT1 protein (n = 6). F Representative photographs of TUNEL/DAPI double staining of the cardiomyocytes after MIR (×630). H The quantitative analysis of TUNEL/DAPI (n = 6). G Representative figures of expression of Bax and Bcl-2. I Quantitative analyses of Bax and Bcl-2 protein (n = 6). *P 

2). Puerarin suppresses macrophage M1 polarization to alleviate renal inflammatory injury through antagonizing TLR4/MyD88-mediated NF-κB p65 and JNK/FoxO1 activation. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2024 (PubMed: 38905846) [IF=6.7]

3). Schisandra chinensis Lignans Exert Antidepressant Effects by Promoting BV2 Microglia Polarization toward the M2 Phenotype through the Activation of the Cannabinoid Receptor Type-2–Signal Transducer and Activator of Transcription 6 Pathway. Journal of Agricultural and Food Chemistry, 2022 (PubMed: 36349542) [IF=5.7]

4). A novel small molecule RK-019 inhibits FGFR2-amplification gastric cancer cell proliferation and induces apoptosis in vitro and in vivo. Frontiers in Pharmacology, 2022 (PubMed: 36210834) [IF=5.6]

5). Palmitic Acid Inhibits the Growth and Metastasis of Gastric Cancer by Blocking the STAT3 Signaling Pathway. Cancers, 2023 (PubMed: 36672337) [IF=5.2]

6). Oxalate stimulates macrophage secretion of prostaglandin E2 to promote renal tubular epithelial cell osteogenesis. Life sciences, 2025 (PubMed: 39986650) [IF=5.2]

7). Maresin 1 alleviates sevoflurane-induced neuroinflammation in neonatal rats via JAK2/STAT3/IL-6 pathways. International Immunopharmacology, 2022 (PubMed: 35729840) [IF=4.8]

Application: WB    Species: Rat    Sample: hippocampus

Fig. 5. MaR1 inhibits the activation of JAK2/STAT3 signaling pathway. A-C MaR1 deactivated JAK2/STAT3 pathway in hippocampus shown by Western blotting using JAK2/STAT3 antibodies (A) and quantitative analysis (B, C). One-way ANOVA, [pJAK2] F(3, 8) = 6.753, p = 0.0154; [pSTAT3] F(3, 8) = 5.325, p = 0.0245, n = 3. D,E MaR1 inactivated GSK3β pathway in hippocampus shown by Western blotting (D) and quantitative analysis (E). One-way ANOVA, [pS9] F(3, 8) = 7.565, p = 0.0112, n = 3. F Predicted STAT3′ s binding motifs on the promoter of IL-6 were examined by dual luciferase reporter assay. Unpaired t-test, [Motif3] t = 3.546 df = 4, p = 0.0116, n = 3. * p < 0.05; # p < 0.05. Data were presented as mean ± SEM.

8). Tert-Butylhydroquinone Mitigates T-2-Toxin-Induced Testicular Dysfunction by Targeting Oxidative Stress, Inflammation, and Apoptosis in Rats. Toxics, 2024 (PubMed: 38787114) [IF=4.6]

Application: WB    Species: Rat    Sample:

Figure 3 tBHQ alleviates the inflammatory response induced by T-2. (A) mRNA expression levels of inflammatory factors; (B,D) protein expression levels and phosphorylation of JAK, represented by grayscale values; (C,E) protein expression levels and phosphorylation of STAT3, represented by grayscale values. n = 8. * represents a significant difference, with p < 0.05. ** represents a significant difference, with p < 0.01.

9). Transcriptional Regulation of Voltage-Gated Sodium Channels Contributes to GM-CSF-Induced Pain. JOURNAL OF NEUROSCIENCE, 2019 (PubMed: 31015342) [IF=4.4]

Application: WB    Species: rat    Sample: DRG neurons

Figure 5. | GM-CSF increase the mRNA expression level of Nav1.7, Nav1.8, 822 Nav1.9 channel through Jak2-Stat3 signaling pathway. (A) Relative expression of 823 p-Jak1, p-Jak2, p-Jak3, p-stat3 and p-stat5 in DRG neurons after incubation with 824 GM-CSF for 25 mins. (n=3, unpaired t-test, *P < 0.05 as compared to control)

10). Hyperuricemia induces lipid disturbances mediated by LPCAT3 upregulation in the liver. FASEB JOURNAL, 2020 (PubMed: 32780898) [IF=4.4]

Application: WB    Species: human    Sample: L02 cells

FIGURE 6 |Uric acid induces SREBP-1c activation and JAK2/STAT3 pathway inhibition in vitro.F, p-JAK2 (Tyr1007/1008)/JAK2 and p-STAT3 (Tyr705)/STAT3 protein levels were detected by western blotting.

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.